Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,313 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06974929RecruitingPhase 1/Phase 2
Study of HRS-6209 combinations for breast cancer
This trial tests a new drug called HRS-6209 combined with other treatments for people with breast cancer that has worsened after previous therapy. It aims to find a more effective way to control the cancer.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT06978920RecruitingPhase 1
Stem cell therapy for Parkinson's disease
This early-stage trial tests a new stem cell treatment called NCR201 for people with Parkinson's. It aims to see if the treatment is safe and might help improve symptoms.
Hefei, AnhuiAges 40–75 - NCT06974916Recruiting
Tremor treatment study: focused ultrasound for both sides
This trial tests a second focused ultrasound treatment for people with essential tremor who have already had one side treated. It checks if treating the other side helps control tremors better.
TurkuAges 18 years+ - NCT06981741RecruitingPhase 1/Phase 2
Stem cell treatment for knee cartilage damage
This trial tests whether a new stem cell treatment, given during a surgical procedure, can help repair damaged cartilage in the knee. It is for people with moderate to severe knee pain and a specific size of cartilage injury.
AltenburgAges 18–60 - NCT06859775RecruitingPhase 1/Phase 2
SHR-A1811 combination for recurrent or metastatic cervical cancer
This study tests whether a new drug combination called SHR-A1811 can help people with cervical cancer that has come back or spread. It aims to find a better treatment option for those who have limited choices.
Beijing, Beijing MunicipalityAges 18–75 - NCT06980077RecruitingPhase 2
Ivonescimab for advanced thymic carcinoma
This trial tests a new drug called ivonescimab for thymic carcinoma that has come back or isn't responding to other treatments. It aims to see if this drug can shrink the cancer and help you feel better.
Davis, CaliforniaAges 18 years+ - NCT06981351Recruiting
Matching addiction treatment to thinking skills in prison
This trial tests whether matching treatment to specific thinking and learning problems can help people in prison who have struggled with drugs or alcohol. If you join, you may get a program designed just for your needs.
Albuquerque, New MexicoAges 18–55 - NCT06976424RecruitingPhase 4
Face cream with or without laser for excess facial hair in women
This study tests whether combining a face cream with a laser treatment works better than the cream alone for reducing unwanted facial hair in women. It aims to find a more effective treatment for hirsutism (excess hair growth).
Peshawar, KpkAges 18–45 - NCT06980259Recruiting
Comparing two types of radiation for soft tissue sarcoma
This trial tests a newer way of giving radiation (spatially fractionated) compared to standard radiation for people with large soft tissue sarcomas. It aims to see if the new method works better.
Jinan, ShandongAges 18–70 - NCT06973512Recruiting
Brain stimulation for severe addiction
This trial tests a new brain stimulation approach for people with severe addiction that hasn't gotten better with other treatments. It uses deep brain stimulation guided by brain mapping to try to reduce cravings and help you stay abstinent.
Toronto, OntarioAges 25–65 - NCT06980103Recruiting
Decision aid for RAI in thyroid cancer
This trial offers a decision aid to help you choose whether to have radioactive iodine (RAI) treatment after thyroid cancer surgery. You may qualify if you have intermediate-risk thyroid cancer and haven't yet made a decision about RAI.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06977646Enrolling by invitation
Heart surgery for apical hypertrophic cardiomyopathy without valve pressure
This study looks at people who have had surgery to reshape the left side of the heart for a specific type of thickened heart muscle (apical hypertrophic cardiomyopathy). It helps doctors understand how well this surgery works in patients without a large pressure difference across the heart valve.
Moscow, MoscowAges 15 years+ - NCT06977594Recruiting
Preventing allergic reactions during chemo for gynecologic cancer
This study tests a proactive approach to reduce allergic reactions to common chemotherapy drugs (paclitaxel and carboplatin) used for gynecologic cancers. It aims to make treatment safer and more comfortable for patients.
SeoulAges 19 years+ - NCT06976840Recruiting
Rapid antidepressant effects of new brain stimulation methods
This trial tests whether two types of non-invasive brain stimulation can quickly improve depression symptoms. It may be an option for adults with major depression who are not currently taking psychiatric medication.
Pittsburgh, PennsylvaniaAges 18–55 - NCT06982105RecruitingPhase 4
Comparing two antibiotics for children with MRSA bone or head infections
This study compares two oral antibiotics, TMP-SMX and clindamycin, to see which works better for children with MRSA infections in bones, joints, or head/neck areas. It aims to find the best treatment after initial IV therapy.
Indianapolis, IndianaAges 2 months–18 years - NCT06979895Recruiting
Gene changes in gastric cancer treatment monitoring
This trial looks at how gene changes called methylation can help doctors track how well treatment is working for gastric cancer. If you are newly diagnosed and have not had surgery or chemotherapy yet, you may be able to join.
Xi'an, ShaanxiAges 18–75 - NCT06981065Recruiting
Scandinavian study for displaced collar bone fractures
This trial tests different treatments for a specific type of broken collar bone (the outer end, near the shoulder) where the bone pieces are out of place. If you have this type of fracture, the study aims to find the best way to help it heal.
OdenseAges 18–65 - NCT06976853RecruitingPhase 2
Testing a new drug for Crohn’s disease beyond inflammation
This study tests a medicine called tirzepatide to see if it can help people with active Crohn’s disease who have not responded to multiple prior treatments. It focuses on how the drug might work beyond just reducing inflammation.
Beverly Hills, CaliforniaAges 18–80 - NCT06981637RecruitingPhase 2
PLD vs. observation for advanced soft tissue sarcoma
This trial tests whether a type of chemotherapy called pegylated liposomal doxorubicin (PLD) can help keep advanced soft tissue sarcoma from growing after successful first treatment with standard anthracycline-based chemo. You may be eligible if you've completed 4-8 cycles of that initial chemo and your disease is controlled (shrank or stable).
Kaohsiung CityAges 18 years+ - NCT06976125Recruiting
Using a model to guide antibiotic choice for UTI after ER visit
This trial tests whether a prediction model can help doctors choose the right antibiotic for women with a urinary tract infection (UTI) after an emergency room visit. It aims to improve treatment and reduce unnecessary antibiotics.
Cleveland, OhioAges 18 years+ - NCT06979869Recruiting
Esophageal cancer gene test for treatment response
This trial uses a blood test to track genetic changes in esophageal cancer over time. It aims to see if these changes can show how well treatment is working.
Wuwei, GansuAges 18–75 - NCT06976437RecruitingEarly Phase 1
Testing donor CAR-T cells for B-cell blood cancers
This trial tests a new treatment using specially engineered immune cells from a healthy donor to fight certain B-cell blood cancers that have come back or not responded to standard therapy. It aims to see if these cells can safely help patients achieve remission.
Zhenjiang, JiangsuAges 18 years+ - NCT06969612RecruitingPhase 1
New drug combo as first treatment for advanced lung cancer
This trial tests a new combination of three medicines (Golidocitinib, Tislelizumab, and chemotherapy) as the first treatment for advanced non-small cell lung cancer (NSCLC). It is designed for people whose tumors have at least 1% PD-L1 and who have not had any previous treatment for advanced disease.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06929936RecruitingPhase 2
Trilaciclib plus docetaxel for advanced lung cancer (second-line+)
This trial tests a new drug combination (trilaciclib plus docetaxel) for people with advanced lung cancer (NSCLC) whose cancer has progressed after at least one prior treatment. The goal is to see if adding trilaciclib helps the chemotherapy work better with fewer side effects.
Xiamen, FujianAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,313 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.